Average weight loss of ~17% if all patients stayed on treatment* with Wegovy® (semaglutide) tablets 25 mg (~14% regardless of if patients stayed on treatment**) in the OASIS 4 trial1 1.5 mg starting dose available in early January for $149 per month with savings offers; Wegovy® pill is being produced in the US and robust supply is on-hand Wegovy® brand is the only GLP-1 indicated for weight loss proven to help prevent life-threatening CV events for adults with established CVD and either overwei...